Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14,034 | -9,064 | N/A | N/A |
| Depreciation Amortization | 17 | 17 | N/A | N/A |
| Accounts payable and accrued liabilities | 157 | -90 | N/A | N/A |
| Other Working Capital | 564 | 725 | N/A | N/A |
| Other Operating Activity | 467 | 504 | 0 | 0 |
| Operating Cash Flow | $-12,829 | $-7,908 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2 | -12 | N/A | N/A |
| Investing Cash Flow | $-2 | $-12 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 124 | N/A | N/A |
| Other Financing Activity | 0 | 27,359 | 0 | 0 |
| Financing Cash Flow | $N/A | $27,483 | $N/A | $N/A |
| Beginning Cash Position | 34,599 | 15,036 | N/A | N/A |
| End Cash Position | 21,768 | 34,599 | N/A | N/A |
| Net Cash Flow | $-12,831 | $19,563 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -12,829 | -7,908 | N/A | N/A |
| Capital Expenditure | -2 | -12 | N/A | N/A |
| Free Cash Flow | -12,831 | -7,920 | 0 | 0 |